Russell Investments Group
IPXL

Russell Investments Group’s Impax Laboratories, Inc. IPXL Stock Holding History

Russell Investments Group’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-25,650
Closed -$499K – 3029
2018
Q1 		$499K Buy
25,650
+2,100
+9% +$41.2K ﹤0.01% 2477
2017
Q4 		$397K Sell
23,550
-43,050
-65% -$789K ﹤0.01% 2504
2017
Q3 		$1.35M Buy
+66,600
New +$1.27M ﹤0.01% 1981

Russell Investments Group's IPXL Position: Q2 2018 in Review

Russell Investments Group sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 25,650 shares — an estimated $499K sold.

Russell Investments Group first reported a position in IPXL in Q3 2017 and held it in 3 quarters. The position peaked at $1.35M in Q3 2017. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

  • Russell Investments Group reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
  • Russell Investments Group sold 25,650 Impax Laboratories, Inc. shares in Q2 2018, an estimated $499K.
  • Russell Investments Group first reported a position in Impax Laboratories, Inc. in Q3 2017 and held it in 3 quarters.
  • Russell Investments Group's Impax Laboratories, Inc. position peaked at $1.35M in Q3 2017.
  • 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Russell Investments Group's 13F filing for Q2 2018, filed 8 Aug 2018.